Vasculogenic mimicry: Current status and future prospects

Cancer Letters

Volumn 254, Issue 2, 2007, Pages 157-164

  Zhang, Shiwu ^a   Zhang, Danfang ^a   Sun, Baocun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Highly aggressive melanoma; Laminin; Linearly patterned programmed cell necrosis; Metalloproteinases; Three stage phenomenon; Tyrosine kinases; Uveal melanoma; Vasculogenic mimicry; VE cadherin; VM targeted therapy

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CELL ADHESION MOLECULE; COLLAGEN TYPE 4; COLLAGEN TYPE 6; EPHRIN RECEPTOR A2; GELATINASE A; GELATINASE B; GLYCOSAMINOGLYCAN; HEPARIN; INTERSTITIAL COLLAGENASE; LAMININ; MATRIX METALLOPROTEINASE 14; MELANIN; METALLOPROTEINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGRAPHY; APOPTOSIS; BREAST CANCER; C57BL MOUSE; CELL ADHESION; CELL CULTURE; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; GASTROINTESTINAL STROMAL TUMOR; GENE TARGETING; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LASER SCANNING CONFOCAL ANGIOGRAPHY; LIVER CANCER; NONHUMAN; OVARY CANCER; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; PROSTATE CANCER; SHORT SURVEY; SYSTEMATIC REVIEW; TUMOR VASCULARIZATION; UVEA MELANOMA;

EID: 34547142222     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.12.036     Document Type: Review

References (48)

1. Maniotis A.J.F.R., Hess A., Seftor E.A., Gardner L.M., Pe'er J., Trent J.M., Meltzer P.S., and Hendrix M.I. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155 3 (1999) 739-752
2. Folberg R.M.A. Vasculogenic mimicry. APMIS 112 7-8 (2004) 508-525
3. Sood A.K.K.M., Coffin J.E., Yang M., Seftor E.A., Gruman L.M., Gershenson D.M., and Hendrix M.J. Functional role of matrix metalloproteinases in ovarian tumor cell plasticity. Am. J. Obstet. Gynecol. 190 4 (2004) 899-909
4. Zhang S.Z.D., Wang Y., Zhao W., Guo H., Zhao X., and Sun B. Morphologic research of microcirculation patterns inhuman and animal melanoma. Med. Oncol. 23 3 (2006) 403-410
5. Chen X.M.A., Majumdar D., Pe'er J., and Folberg R. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity. Invest. Ophthalmol. Vis. Sci. 43 8 (2002) 2533-2539
6. Clarijs R.O.-H.L., Ruiter D.J., and de Waal R.M. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Invest. Ophthalmol. Vis. Sci. 43 4 (2002) 912-918
7. Folberg R.H.M., and Maniotis A.J. Vasculogenic mimicry and tumor angiogenesis. Am. J. Pathol. 156 2 (2000) 361-381
8. Hendrix M.J.S.E., Kirschmann D.A., Quaranta V., and Seftor R.E. Remodeling of the microenvironment by aggressive melanoma tumor cells. Ann. NY Acad. Sci. 995 (2003) 151-161
9. Hendrix M.J.S.E., Meltzer P.S., Gardner L.M., Hess A.R., Kirschmann D.A., Schatteman G.C., and Seftor R.E. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc. Natl. Acad. Sci. USA 98 14 (2001) 8018-8023
10. Shirakawa K.W.H., Heike Y., Watanabe I., Yamada S., Saito K., and Konishi F. Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int. J. Cancer 99 6 (2002) 821-828
11. Sun B.Z.S., Zhao X., Zhang W., and Hao X. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Int. J. Oncol. 25 6 (2004) 1609-1614
12. Shirakawa K.K.H., Heike Y., Kawamoto S., Brechbiel M.W., Kasumi F., Iwanaga T., Konishi F., Terada M., and Wakasugi H. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res. 62 2 (2002) 560-566
13. Sharma N.S.R., Seftor E.A., Gruman L.M., Heidger Jr. P.M., Cohen M.B., Lubaroff D.M., and Hendrix M.J. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50 3 (2002) 189-201
14. Warren B.A.S.P. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab. Invest. 15 2 (1966) 464-478
15. Nasu R.K.H., Akagi K., Murata T., and Tanaka Y. Blood flow influences vascular growth during tumour angiogenesis. Br. J. Cancer 79 5-6 (1999) 780-786
16. Chang Y.S.d.T.E., McDonald D.M., Jones R., Jain R.K., and Munn L.L. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc. Natl. Acad. Sci. USA 97 26 (2000) 14608-14613
17. McDonald D.M.M.L., and Jain R.K. Vasculogenic mimicry: how convincing, how novel, and how significant?. Am. J. Pathol. 56 2 (2000) 383-388
18. Seftor R.E.S.E., Koshikawa N., Meltzer P.S., Gardner L.M., Bilban M., Stetler-Stevenson W.G., Quaranta V., and Hendrix M.J. Cooperative interactions of laminin 5γ2 chain, matrix metallopmteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res. 61 17 (2001) 6322-6337
19. Seftor R.E.S.E., Kirschmann D.A., and Hendrix M.X. Targeting the tumor microenvironment with chemically modified tetracylines: inhibition of laminin 5γ2 chain promigratory fragments and vasculogenic mimicry. Mol. Cancer Ther. 1 13 (2002) 1173-1179
20. Hess A.R.S.E., Seftor R.E., and Hendrix M.J. Phosphoinositide 3-kinase regulates membrane Type 1-matrix metallopmteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry. Cancer Res. 63 16 (2003) 4757-4762
21. Seftor E.A.M.P., Schatteman G.C., Gruman L.M., Hess A.R., Kirschmann D.A., Seftor R.E., and Hendrix M.J. Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit. Rev. Oncol. Hematol. 44 1 (2002) 17-27
22. Seftor E.A.M.P., Kirschmann D.A., Margaryan N.V., Seftor R.E., and Hendrix M.J. The epigenetic reprogramming of poorly aggressive melanoma c ells by a metastatic microenvironment. J. Cell Mol. Med. 10 1 (2006) 174-196
23. Seftor E.A.M.P., Kirschmann D.A., Pe'er J., Manbtis A.J., Trent J.M., Folberg R., and Hendrix M.I. Molecular determinants of human uveal melanoma invasion and metastasis. Clin. Exp. Metastasis 19 3 (2002) 233-246
24. Hendrix M.J.S.E., Kirschmann D.A., and Seftor R.E. Molecular biology of breast cancer metastasis. Molecular expression of vascular markers by aggressive breast cancer cells. Breast Cancer Res. 2 6 (2000) 417-422
25. Hess A.R.S.E., Gardner L.M., Carks-Kinch K., Schneider G.B., Seftor R.E., Kinch M.S., and Hendrix M.J. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res. 61 8 (2001) 3250-3255
26. Hoffmeyer M.R.W.K., and Dharmawardhane S.F. In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line. Cancer Cell Int. 5 1 (2005) 11
27. Michel G.M.E., Ernest I., Roland I., Durant F., Remacle J., and Michiels C. A model for the complex between the hypoxia-inducible factor-1 (HTF-1) and its consensus DNA sequence. J. Biomol. Struct. Dyn. 18 2 (2000) 169-179
28. Shams I.A.A., and Nevo E. Hypoxic stress tolerance of the blind subterranean mole rat: expression of erythmpoietin and hypoxia-inducible factor 1 alpha. Proc. Natl. Acad. Sci. USA 101 26 (2004) 9698-9703
29. Jung F.P.L., Zhou N., and Johns R.A. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ. Res. 86 3 (2000) 319-325
30. Olenyuk B.Z.Z.G., Klco J.M., Nickols N.G., Kaelin Jr. W.G., and Dervan P.B. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc. Natl. Acad. Sci. USA 101 48 (2004) 16768-16773
31. Hess A.R.S.E., Gruman L.M., Kinch M.S., Seftor R.E., and Hendrix M.J. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol. Ther. 5 2 (2006) 228-233
32. Hao X.S.S.B., Zhang S.W., and Zhao X.L. Correlation between the expression of collagen IV, VEGF and vasculogenic mimicry. Zhonghua Zhong Liu Za Zhi 25 6 (2003) 524-526
33. Kim S.J.R.Z., Dewhirst M.W., Vujaskovic Z., Vollmer R.T., Schreiber E.G., Oosterwijk E., and Kelley M.J. Expression of HIF-lα, CA DC, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 49 3 (2005) 325-335
34. Fujimoto A.O.H., Mori A., Nagayama S., Yonenaga Y., and Tachibana T. Tumour plasticity and extravascular circulation in ECV304 human bladder carcinoma cells. Anticancer Res. 26 1A (2006) 59-69
35. Sun B.Z.D., Zhang S., Zhang W., Guo H., and Zhao X. Hypoxia influences vasculogenic mimicry channel formation and tumor invasion-related protein expression in melanoma. Cancer Lett. (2006)
36. B. Sun, S. Zhang, D. Zhang, Elementary study of the relationship between linearly patterned programmed cell necrosis and the succession of blood supply vessel types in melanoma, Chinese J. Clin. Oncol. (2007), accepted for publication.
37. Hao X.S.B., Zhang S., and Zhao X. Microarray study of vasculogenic mimicry in bi-directional differentiation malignant tumor. Zhonghua YiXue Za Zhi. 82 19 (2002) 1298-1302
38. Gumbiner B.M. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84 3 (1996) 345-357
39. Hwu W.J. New approaches in the treatment of metastatic melanoma: thalidomide and temozolomide. Oncology (Williston Park) 14 12 Suppl. 13 (2002) 25-28
40. Clarijs R.S.L., Ruiter D.J., and de Waal R.M. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma. Invest. Ophthalmol. Vis. Sci. 42 7 (2001) 1422-1428
41. Laakkonen P.P.K., Hoffman J.A., and Ruoslahti E. A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 8 7 (2002) 751-755
42. Hendrix M.J.S.E., Hess A.R., and Seftor R.E. Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer 3 6 (2003) 411-421
43. Zhang S.G.H., Zhang D., Zhang W., Zhao X., Ren Z., and Sun B. Microcirculation patterns in different stages of melanoma growth. Oncol. Rep. 15 1 (2006) 15-20
44. van der Schaft D.W.S.R., Seftor E.A., Hess A.R., Gruman L.M., Kirschmann D.A., Yokoyama Y., Griffioen A.W., and Hendrix M.J. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J. Natl. Cancer Inst. 96 19 (2004) 1473-1477
45. Rybak S.M.S.E., Hollingshead M.G., Borgel S.D., Newton D.L., Melillo G., Kong D., Kaur G., and Sausville E.A. "Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies. Cancer Res. 63 11 (2003) 2812-2819
46. Sanz L.K.M., Blanco B., Serrano A., and Alvarez-Vaflina L. Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells. Cancer Immunol. Immunother. 52 10 (2003) 643-647
47. Basu G.D.P.L., Tinder T.L., Gendler S.J., and Mukherjee P. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells. Breast Cancer Res. 7 4 (2005) R422-R435
48. Ruf W.S.E., Petrovan R.J., Weiss R.M., Gruman L.M., Margaryan N.V., Seftor R.E., Miyagi Y., and Hendrix M.J. Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry. Cancer Res. 63 17 (2003) 5381-5389